Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.